B-CELL MALIGNANCY

Clinical trials for B-CELL MALIGNANCY explained in plain language.

Never miss a new study

Get alerted when new B-CELL MALIGNANCY trials appear

Sign up with your email to follow new studies for B-CELL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1 Terminated 1

CRISPR-Tweaked donor cells take on Hard-to-Treat blood cancers

Disease control Terminated

This study tested a new treatment called CTX110 for people with B-cell blood cancers that came back or didn't respond to standard therapy. CTX110 uses donor immune cells that are edited with CRISPR technology to target and attack cancer cells. The trial enrolled 93 adults and aim…

Matched conditions: B-CELL MALIGNANCY

Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control

Last updated Jun 27, 2026 07:55 UTC

B-CELL MALIGNANCY

Get alerted when new B-CELL MALIGNANCY trials appear

CRISPR-Tweaked donor cells take on Hard-to-Treat blood cancers